Literature DB >> 2107249

Clinical predictors of infection of central venous catheters used for total parenteral nutrition.

C W Armstrong1, C G Mayhall, K B Miller, H H Newsome, H J Sugerman, H P Dalton, G O Hall, S Hunsberger.   

Abstract

To identify predictors of infection in catheters used for total parenteral nutrition (TPN), clinical and microbiological data were prospectively collected on 169 catheter systems (88 patients). Based on semiquantitative catheter cultures, infection was associated with a positive insertion site skin culture taken close to the time of catheter removal (relative risk [RR] = 4.50), especially one yielding greater than or equal to 50 colonies of an organism other than coagulase-negative staphylococci. Infection was also associated with erythema at the insertion site greater than 4 mm in diameter (RR = 2.93). In a subset of 67 catheters for which blood cultures were obtained, infection was also associated with a positive peripheral venous blood culture (RR = 5.90) and a positive central venous blood culture obtained through the catheter (RR = 5.44). Based on a logistic regression model, periodic cultures of the insertion site should be useful in evaluating subsequent fever in stable patients with indwelling central venous catheters. Another source of fever is likely if inflammation is absent and there is either no colonization or there is colonization by less than 50 colonies of coagulase-negative staphylococci at the insertion site. Conversely, the catheter should be removed and cultured semiquantitatively if the site is colonized by an organism other than coagulase-negative staphylococci. We suggest that blood culture results add little to the risk estimate in these situations.

Entities:  

Mesh:

Year:  1990        PMID: 2107249     DOI: 10.1086/646125

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  8 in total

1.  Suspected central venous catheter-associated infection: can the catheter be safely retained?

Authors:  Christian Brun-Buisson
Journal:  Intensive Care Med       Date:  2004-03-02       Impact factor: 17.440

2.  Current issues and perspectives: Prevention of central venous catheter infections.

Authors:  J Conly; S Shafran
Journal:  Can J Infect Dis       Date:  1992-01

3.  Serial surveillance cultures of skin and catheter hub specimens from critically ill patients with central venous catheters: molecular epidemiology of infection and implications for clinical management and research.

Authors:  I Atela; P Coll; J Rello; E Quintana; J Barrio; F March; F Sanchez; P Barraquer; J Ballus; A Cotura; G Prats
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

4.  Diagnosis of vascular catheter-related bloodstream infection: a meta-analysis.

Authors:  Y Siegman-Igra; A M Anglim; D E Shapiro; K A Adal; B A Strain; B M Farr
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

Review 5.  Epidemiology, therapy and costs of nosocomial infection.

Authors:  R Gálvez-Vargas; A Bueno-Cavanillas; M García-Martín
Journal:  Pharmacoeconomics       Date:  1995-02       Impact factor: 4.981

Review 6.  Pathogenesis of infections related to intravascular catheterization.

Authors:  D A Goldmann; G B Pier
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

7.  Incidence and clinical implication of nosocomial infections associated with implantable biomaterials - catheters, ventilator-associated pneumonia, urinary tract infections.

Authors:  Josef Peter Guggenbichler; Ojan Assadian; Michael Boeswald; Axel Kramer
Journal:  GMS Krankenhhyg Interdiszip       Date:  2011-12-15

8.  Local signs at insertion site and catheter-related bloodstream infections: an observational post hoc analysis using individual data of four RCTs.

Authors:  Niccolò Buetti; Stéphane Ruckly; Jean-Christophe Lucet; Lila Bouadma; Maité Garrouste-Orgeas; Carole Schwebel; Olivier Mimoz; Bertrand Souweine; Jean-François Timsit
Journal:  Crit Care       Date:  2020-12-14       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.